Scope and Limitations of the Use of Methanesulfonic Acid (MSA) as a Green Acid for Global Deprotection in Solid‐Phase Peptide Synthesis
ChemSusChem · 02.06.2025 · 18 (11)
DOI: 10.1002/cssc.202402752 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemSusChem, online erschienen am 21.02.2025. Verfasst von Giovanni Vivenzio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban, 4001, South Africa. Hauptthemen laut MEDLINE: Peptides, Solid-Phase Synthesis Techniques, Mesylates, Green Chemistry Technology. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
N,N‐dimethylformamide (DMF) and trifluoroacetic acid (TFA) are the two solvents/reagents most widely used in solid‐phase peptide synthesis (SPPS). While DMF is already regulated in Europe, TFA – a member of the polyfluoroalkyl substances (PFAS) family – is expected to face similar restrictions soon. These compounds break down slowly and pose risks to human health and the environment. Herein, the use of the so‐called “green acid par excellence”, methanesulfonic acid (MSA), in substitution of TFA is discussed. As MSA is stronger than TFA, it is diluted with a solvent for use. The effectivity of MSA depends on the solvents used. When dichloromethane (DCM) is used, 1.5 % MSA removes all side‐chain protecting groups, except the trityl (Trt) group of His. In the presence of acetic acid (AcOH) and dimethylcarbonate (DMC), more concentrated solutions of MSA (8–16 %) are required. The removal of the Trt group of Asn/Gln continues to be a challenge even with these solutions, and aspartimide formation can occur in Asp‐containing peptides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban, 4001, South Africa.
- Department of Pharmacy, University of Salerno, 84084-, Fisciano, Italy.
- School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa.
- Novartis Pharma AG, 4056-, Basel, Switzerland.
- Department of Organic Chemistry, University of Barcelona, Martí i Franqués 1-11, 08028-, Barcelona, Spain.
ORCID-Profile: Fernando Albericio
Zitieren
APA
Vivenzio, G., Noki, S., Chakraborty, A., Lopez, J., de la Torre, B. G., & Albericio, F. (2025). Scope and Limitations of the Use of Methanesulfonic Acid (MSA) as a Green Acid for Global Deprotection in Solid‐Phase Peptide Synthesis. ChemSusChem, 18(11). https://doi.org/10.1002/cssc.202402752
Vancouver
Vivenzio G, Noki S, Chakraborty A, Lopez J, de la Torre BG, Albericio F. Scope and Limitations of the Use of Methanesulfonic Acid (MSA) as a Green Acid for Global Deprotection in Solid‐Phase Peptide Synthesis. ChemSusChem. 2025;18(11). doi:10.1002/cssc.202402752
BibTeX
@article{Vivenzio2025,
author = {Vivenzio, Giovanni and Noki, Sikabwe and Chakraborty, Amit and Lopez, John and de la Torre, Beatriz G and Albericio, Fernando},
title = {Scope and Limitations of the Use of Methanesulfonic Acid (MSA) as a Green Acid for Global Deprotection in Solid‐Phase Peptide Synthesis},
journal = {ChemSusChem},
year = {2025},
volume = {18},
number = {11},
doi = {10.1002/cssc.202402752}
}
EUVIMED